{'fraction_non_alphanumeric': 0.019652305366591082, 'fraction_numerical': 0.009826152683295541, 'mean_word_length': 6.480225988700565, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Heparan sulfate depletion within pulmonary fibroblasts: Implications for elastogenesis and repair

We investigated the role of sulfated proteoglycans in regulating extracellular matrix (ECM) deposition in pulmonary fibroblast cultures. Fibroblast cultures were subject to pharmacologic and enzymatic interventions to modify sulfated proteoglycan levels. Native and proteoglycan‐depleted fibroblasts were treated with porcine pancreatic elastase at 2–4‐day intervals and the elastase‐mediated release of fibroblast growth factor 2 (FGF‐2) and glycosaminoglycans was determined. Elastase treatment released significantly less FGF‐2 and glycosaminoglycans (GAG) from PG‐depleted fibroblasts with respect to native cells. Equilibrium ligand binding studies indicated that 125I FGF‐2 binding at both cell surface receptor and heparan sulfate proteoglycan sites was reduced to different extents based on the method of proteoglycan depletion. Quantitation of elastin protein and message levels indicated that biological sulfation is required for the proper incorporation of tropoelastin into the extracellular matrix. These results suggest that sulfated proteoglycans play a central role in modulating pulmonary fibroblast extracellular matrix composition and are important mediators of elastolytic injury. © 2002 Wiley‐Liss, Inc.